Medical Pearl: Interpretation of tuberculin skin tests in patients who have received the BCG vaccine

Journal of the American Academy of Dermatology

Volumn 53, Issue 5, 2005, Pages 868-869

  Desai, Anupam M ^a   Hsu, Sylvia ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; PREDNISONE; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; DRUG USE; HEALTH CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; SKIN TEST; THORAX RADIOGRAPHY; TUBERCULOSIS;

BCG VACCINE; HUMANS; TUBERCULIN TEST;

EID: 27144451425     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.05.034     Document Type: Article

References (5)

1. M.A. Gardam, E.C. Keystone, R. Menzies, S. Manners, E. Skamene, and R. Long Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management Lancet Infect Dis 3 2003 148 155
2. Targeted tuberculin testing and treatment of latent tuberculosis. American Thoracic Society MMWR Recomm Rep 49 RR-6 2000 1 51
3. J.P. Myers New recommendations for the treatment of tuberculosis Curr Opin Infect Dis 18 2005 133 140
4. Diagnostic standards and classification of tuberculosis in adults and children Am J Respir Crit Care Med 161 2000 1376 1395
5. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices MMWR Recomm Rep 45 RR-4 1996 1 18